Status:
COMPLETED
Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide
Lead Sponsor:
University of Utah
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Up to 28 years
Brief Summary
This is a chart review study of neonates admitted to Primary Children's Medical Center or University of Utah NICU who had or developed a diagnosis of bronchopulmonary dysplasia (BPD) and were treated ...
Detailed Description
Recent studies (e.g. Schreiber 2003)1 have prompted several large current clinical trials on the use of inhaled nitric oxide (iNO) for the prevention of bronchopulmonary dysplasia (BPD) in preterm inf...
Eligibility Criteria
Inclusion
- Any patient who at 28 days of life was requiring oxygen therapy in the Neonatal Intensive Care Unit and who was then treated with iNO would be eligible for chart review. Since iNO therapy has only been available for a few years, this study will attempt to capture all patients who qualify.
Exclusion
- Any patient who received iNO treatment under an IRB study protocol after 28d of life would not be eligible for chart review.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00757146
Start Date
March 1 2006
End Date
February 1 2010
Last Update
June 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univesity of Utah / Primary Childrens Medical Center
Salt Lake City, Utah, United States, 84132